Paediatric obesity has become one of the most global health challenges of the 21st century. Its prevalence has dramatically increased over the past few decades, with significant consequences for child development and long-term health.
Paediatric obesity is not only a matter of excess weight, but it is a complex condition with multifactorial origins. Genetic predisposition, environmental factors, and lifestyle choices all contribute. Obesity in children is linked to a spectrum of endocrine comorbidities, including type 2 diabetes, dyslipidemia, metabolic syndrome, polycystic ovary syndrome, and central precocious puberty.
Let me explain what happens metabolically.
In a child with obesity, adipose tissue functions as energy storage and an active endocrine organ. These enlarged fat cells release inflammatory cytokines like TNF-alpha and IL-6, creating a state of chronic low-grade inflammation. Simultaneously, they become resistant to insulin’s effects, forcing the pancreatic beta cells to compensate by secreting increasing amounts of insulin.
This hyperinsulinemia becomes the driving force behind many of the endocrine disruptions. In female patients who are obese, excess insulin stimulates ovarian theca cells to overproduce androgens, leading to premature adrenarche and polycystic ovary syndrome. Obesity plays a significant role in central precocious puberty.
It is characterised by early hypothalamic-pituitary-gonadal axis activation, leading to the premature development of secondary sexual characteristics. Adipose tissue produces leptin, a hormone that, at elevated levels, can stimulate the onset of puberty. Additionally, obesity-induced insulin resistance and hyperinsulinemia may further promote early pubertal development.
Children with obesity often exhibit altered growth hormone dynamics, with decreased spontaneous GH secretion but paradoxically accelerated growth and advanced bone age. This can have an impact on the final adult height.
Thyroid function is another challenge in children with obesity who often experience hyperthyrotropinemia of obesity. That is when there is mild TSH elevation with normal FT4 levels. This condition can be sorted out by weight management rather than thyroid hormone supplementation. More clinical examination is needed to differentiate true hypothyroidism.
Obesity in childhood is associated with increased cortisol reactivity and altered diurnal cortisol rhythms. While not equivalent to cushing’s syndrome, this functional hypercortisolism promotes central fat accumulation, worsens insulin resistance, and contributes to hypertension and dyslipidaemia.
Children with obesity can exhibit signs of functional hypercortisolism due to increased 11β-HSD1 activity in adipose tissue, which mimics Cushingoid features and exacerbates insulin resistance and dyslipidemia.
Early-life obesity leads to metabolic programming, where prolonged exposure to insulin resistance, inflammation, and hormonal imbalance permanently alters endocrine set points. This increases lifelong susceptibility to metabolic syndrome, infertility, osteoporosis, and cardiovascular disease, even if weight is later reduced.
Early intervention is important by promoting healthy eating, physical activity, reducing screen time, and involving families in behavioural change programs. Pharmaceutical interventions such as metformin are considered in cases of insulin resistance or impaired glucose tolerance, through lifestyle modification.
Paediatric obesity is not just a cosmetic issue. It is a significant driver of early-onset endocrine diseases with long-lasting consequences. Recognising the interconnection between adiposity and hormonal dysregulation is key to early diagnosis.
Kripa, is a Specialist Dietitian at The London Obesity & Endocrine Clinic. She has helped many patients overcome weight management barriers. ©Simplyweight
Top obesity clinic in Chennai
